Zomedica Corp. SEC filings ZOMDF

Zomedica Corp. has 482 filings in SEC EDGAR's recent list, going back to Sep 8, 2016. Its latest annual report, Form 10-K, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Zomedica Corp. SEC filings
Form Description Filed Period
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Shareholder vote results
Jun 11, 2026 Jun 10, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
DEF 14A Proxy statement Apr 27, 2026 Apr 24, 2026
DEFA14A Additional proxy material Apr 24, 2026 —
PRE 14A Preliminary proxy statement Apr 14, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 16, 2026 Mar 16, 2026
10-K Annual report Mar 16, 2026 Dec 31, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-A12G Form 8-a12g Aug 20, 2025 —
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Shareholder vote results
Jun 11, 2025 Jun 10, 2025
DEFA14A Additional proxy material Jun 6, 2025 —
DEFA14A Additional proxy material May 30, 2025 —
DEFA14A Additional proxy material May 30, 2025 —
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
DEFA14A Additional proxy material May 13, 2025 —
DEFA14A Additional proxy material Apr 30, 2025 —
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 30, 2025 Apr 30, 2025
8-K Current report
Officer or director change
Apr 30, 2025 Apr 25, 2025
8-K Current report
Results of operations
Mar 14, 2025 Mar 13, 2025
10-K Annual report Mar 13, 2025 Dec 31, 2024
25-NSE Delisting notice Mar 13, 2025 —
8-K Current report
Listing notice
Mar 5, 2025 Mar 4, 2025
8-K Current report
Officer or director change
Dec 19, 2024 Dec 19, 2024
8-K Current report
Material agreement
Nov 19, 2024 Nov 15, 2024
8-K Current report
Results of operations
Nov 8, 2024 Nov 7, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
UPLOAD Letter from the SEC Oct 16, 2024 —
CORRESP Letter to the SEC Oct 9, 2024 —
UPLOAD Letter from the SEC Sep 16, 2024 —
8-K Current report
Results of operations
Aug 14, 2024 Aug 14, 2024
8-K Current report
Officer or director change
Aug 14, 2024 Aug 14, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
S-8 Employee stock plan registration Jul 3, 2024 —
8-K Current report
Shareholder vote results
Jun 7, 2024 Jun 6, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Dec 31, 2023
8-K Current report
Results of operations
Apr 4, 2024 Apr 1, 2024
10-K Annual report Apr 1, 2024 Dec 31, 2023
8-K Current report
Listing notice
Mar 15, 2024 Mar 13, 2024
8-K Current report
Shareholder vote results
Feb 29, 2024 Feb 28, 2024
DEFA14A Additional proxy material Feb 20, 2024 —
DEFA14A Additional proxy material Feb 6, 2024 —
DEFA14A Additional proxy material Jan 31, 2024 —
DEFA14A Additional proxy material Jan 26, 2024 —
DEFA14A Additional proxy material Jan 24, 2024 —
DEFA14A Additional proxy material Jan 17, 2024 —
DEF 14A Proxy statement Jan 17, 2024 Jan 16, 2024
PRE 14A Preliminary proxy statement Jan 5, 2024 Jan 5, 2024
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Material agreement, Agreement ended
Oct 10, 2023 Oct 4, 2023
8-K Current report
Listing notice
Sep 14, 2023 Sep 12, 2023
8-K Current report
Material agreement, Acquisition or sale of assets
Sep 6, 2023 Sep 4, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Shareholder vote results
Jun 14, 2023 Jun 13, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Material agreement
May 11, 2023 May 10, 2023
8-K Current report
Other events
May 9, 2023 May 8, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 13, 2023
8-K Current report
Officer or director change
Mar 17, 2023 Mar 15, 2023
8-K Current report
Results of operations
Mar 15, 2023 Mar 15, 2023
10-K Annual report Mar 15, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 9, 2023 Feb 8, 2023
8-K Current report
Material agreement, Agreement ended, Other events
Jan 24, 2023 Jan 17, 2023
8-K Current report
Material agreement, Other events
Jan 20, 2023 Jan 13, 2023
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Officer or director change
Aug 24, 2022 Aug 23, 2022
8-K Current report
Results of operations
Aug 15, 2022 Aug 15, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Other events
Jul 20, 2022 Jul 15, 2022
8-K Current report
Other events
Jul 11, 2022 Jul 7, 2022
8-K Current report
Acquisition or sale of assets, Unregistered share sale, Other events
Jul 11, 2022 Jul 1, 2022
8-K Current report
Material agreement, Other events
Jun 21, 2022 Jun 14, 2022
8-K Current report
Officer or director change
Jun 15, 2022 Jun 13, 2022
8-K Current report
Shareholder vote results
Jun 9, 2022 Jun 7, 2022
8-K Current report
Results of operations
May 10, 2022 May 10, 2022
10-Q Quarterly report May 10, 2022 Mar 31, 2022
DEFA14A Additional proxy material Apr 26, 2022 —
DEF 14A Proxy statement Apr 26, 2022 Jun 7, 2022
8-K Current report
Results of operations
Mar 1, 2022 Mar 1, 2022
10-K Annual report Mar 1, 2022 Dec 31, 2021
8-K/A Amended current report Dec 10, 2021 Oct 1, 2021
8-K Current report
Officer or director change
Nov 26, 2021 Nov 19, 2021
8-K Current report
Other events
Nov 18, 2021 Nov 16, 2021
8-K Current report
Results of operations
Nov 12, 2021 Nov 12, 2021
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
8-K Current report
Officer or director change
Oct 4, 2021 Oct 1, 2021
8-K Current report
Material agreement, Acquisition or sale of assets, Other events
Oct 1, 2021 Oct 1, 2021
8-K Current report
Officer or director change
Sep 13, 2021 Sep 13, 2021
8-K Current report
Results of operations
Aug 11, 2021 Aug 11, 2021
10-Q Quarterly report Aug 11, 2021 Jun 30, 2021
8-K Current report
Shareholder vote results
Jul 30, 2021 Jul 30, 2021
DEF 14A Proxy statement Jun 21, 2021 Jul 30, 2021
8-K Current report
Officer or director change
May 17, 2021 May 12, 2021
8-K Current report
Results of operations
May 12, 2021 May 12, 2021
10-Q Quarterly report May 12, 2021 Mar 31, 2021
8-K Current report Apr 21, 2021 Apr 19, 2021
8-K Current report
Other events
Mar 16, 2021 Mar 16, 2021
8-K Current report
Other events
Mar 8, 2021 Mar 7, 2021
S-8 Employee stock plan registration Mar 5, 2021 —
8-K Current report
Auditor change
Mar 4, 2021 Feb 26, 2021
8-K Current report
Results of operations
Feb 26, 2021 Feb 26, 2021
10-K Annual report Feb 26, 2021 Dec 31, 2020
8-K Current report
Other events
Feb 23, 2021 Feb 17, 2021
424B5 Prospectus supplement Feb 9, 2021 —
8-K Current report
Material agreement
Feb 9, 2021 Feb 8, 2021
FWP Free writing prospectus Feb 9, 2021 —
FWP Free writing prospectus Feb 8, 2021 —
424B5 Prospectus supplement Feb 8, 2021 —
8-K Current report
Other events
Jan 19, 2021 Jan 12, 2021
8-K Current report
Officer or director change
Jan 5, 2021 Jan 1, 2021
8-K Current report
Officer or director change
Dec 23, 2020 Dec 23, 2020
8-K Current report
Shareholder vote results
Dec 16, 2020 Dec 15, 2020
8-K Current report
Other events
Nov 16, 2020 Nov 13, 2020
10-Q Quarterly report Nov 12, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 12, 2020 Nov 12, 2020
EFFECT Filing Oct 26, 2020 —
425 Form 425 Oct 26, 2020 —
424B3 Prospectus Oct 26, 2020 —
CORRESP Letter to the SEC Oct 22, 2020 —
S-4/A Filing Oct 22, 2020 —
UPLOAD Letter from the SEC Oct 14, 2020 —
S-4 Registration for a merger or exchange Oct 9, 2020 —
8-K Current report
Officer or director change
Oct 6, 2020 Oct 1, 2020
8-K Current report
Shareholder vote results
Sep 28, 2020 Sep 25, 2020
DEFA14A Additional proxy material Sep 14, 2020 —
8-K Current report
Other events
Sep 8, 2020 Sep 8, 2020
8-K Current report
Other events
Aug 27, 2020 Aug 27, 2020
DEFA14A Additional proxy material Aug 27, 2020 —
DEFA14A Additional proxy material Aug 20, 2020 —
DEF 14A Proxy statement Aug 14, 2020 Sep 25, 2020
8-K Current report
Results of operations
Aug 10, 2020 Aug 10, 2020
10-Q Quarterly report Aug 10, 2020 Jun 30, 2020
8-K Current report
Officer or director change, Bylaw or fiscal year change
Aug 7, 2020 Aug 6, 2020
8-K Current report
Officer or director change
Aug 4, 2020 Jul 31, 2020
PRE 14A Preliminary proxy statement Jul 29, 2020 Sep 25, 2020
8-K Current report Jul 29, 2020 Jul 28, 2020
8-K Current report
Officer or director change
Jul 10, 2020 Jul 9, 2020
424B5 Prospectus supplement Jul 6, 2020 —
8-K Current report
Material agreement
Jul 6, 2020 Jul 1, 2020
424B5 Prospectus supplement Jul 1, 2020 —
8-K/A Amended current report
Officer or director change
Jul 1, 2020 Jun 16, 2020
EFFECT Filing Jun 26, 2020 —
424B4 Prospectus Jun 26, 2020 —
CORRESP Letter to the SEC Jun 24, 2020 —
UPLOAD Letter from the SEC Jun 24, 2020 —
S-1 Registration statement Jun 18, 2020 —
8-K Current report
Officer or director change, Other events
Jun 17, 2020 Jun 16, 2020
424B4 Prospectus May 27, 2020 —
EFFECT Filing May 26, 2020 —
S-1/A Amended registration statement May 22, 2020 —
S-1/A Amended registration statement May 21, 2020 —
CORRESP Letter to the SEC May 20, 2020 —
UPLOAD Letter from the SEC May 19, 2020 —
S-1 Registration statement May 15, 2020 —
8-K Current report
Results of operations
May 11, 2020 May 11, 2020
10-Q Quarterly report May 11, 2020 Mar 31, 2020
8-K Current report
Material agreement, New debt
Apr 24, 2020 Apr 20, 2020
8-K Current report
Officer or director change
Apr 22, 2020 Apr 21, 2020
8-K Current report
Listing notice, Other events
Apr 13, 2020 Apr 10, 2020
424B5 Prospectus supplement Apr 8, 2020 —
8-K Current report
Material agreement, Unregistered share sale
Apr 8, 2020 Apr 7, 2020
424B5 Prospectus supplement Apr 7, 2020 —
8-K Current report
Other events
Apr 7, 2020 Apr 7, 2020
8-K Current report
Other events
Apr 1, 2020 Mar 31, 2020
S-8 Employee stock plan registration Mar 18, 2020 —
8-K Current report
Other events
Mar 17, 2020 Mar 13, 2020
8-K Current report
Results of operations
Feb 26, 2020 Feb 26, 2020
10-K Annual report Feb 26, 2020 Dec 31, 2019
D Filing Feb 14, 2020 —
424B5 Prospectus supplement Feb 13, 2020 —
8-K Current report
Material agreement, Unregistered share sale
Feb 13, 2020 Feb 12, 2020
8-K Current report
Material agreement, Other events
Jan 22, 2020 Jan 17, 2020
8-K Current report
Officer or director change
Dec 11, 2019 Dec 2, 2019
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 3, 2019 Dec 2, 2019
8-K Current report
Results of operations
Nov 12, 2019 Nov 12, 2019
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
8-K Current report
Shareholder vote results
Nov 5, 2019 Nov 5, 2019
DEF 14A Proxy statement Sep 27, 2019 Nov 5, 2019
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 17, 2019 Sep 16, 2019
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 19, 2019 Aug 16, 2019
8-K Current report
Results of operations
Aug 8, 2019 Aug 8, 2019

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ZOMDF (OTC)
Fiscal year ends
December 31
Incorporated in
Alberta, Canada
Headquarters
Ann Arbor, MI
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1684144
Former names
Zomedica Pharmaceuticals Corp. (until Sep 28, 2020)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.